Concepedia

Bob Argiropoulos

BA

Statistics

Publications

34

Citations

2.7K

H-Index

25

Active since

2001

Affiliations

BC Cancer Agency(Current)

University of Calgary

Alberta Children's Hospital

University of British Columbia

Medizinische Hochschule Hannover

Bob Argiropoulos is an author at BC Cancer Agency specializing in life sciences, molecular biology, and genetics.

ORCID

Publications per year

2001–2021

34

Publications

34

Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

Daniel T. Starczynowski, Florian Kuchenbauer, Bob Argiropoulos et al. · Nature Medicine · 2009 · 650 citations

, , +12

Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes

A. C. Lionel, Kristiina Tammimies, Andrea K. Vaags et al. · Human Molecular Genetics · 2013 · 175 citations · Full text

, , +17

In-depth characterization of the microRNA transcriptome in a leukemia progression model

Florian Kuchenbauer, Ryan D. Morin, Bob Argiropoulos et al. · Genome Research · 2008 · 174 citations · Full text

, , +17

DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies

Jianling Ji, Hane Lee, Bob Argiropoulos et al. · European Journal of Human Genetics · 2015 · 155 citations

, , +11

MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML

Michael Heuser, Bob Argiropoulos, Florian Kuchenbauer et al. · Blood · 2007 · 148 citations · Full text

, , +13

1–5 of 34